slides · global inventory
27 Cost Of Inaction
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 31,900
Current window 21,931-21,960
Pages 1,064
Rows per page 30
Loop
21,931-21,960 of 31,900
07
The slide uses a table to contrast financial metrics and production strategies, positioning Eos as more efficient than competitors.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
08
The slide uses a three-pillar strategic framework to organize operational improvements.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
09
The slide uses a maturity model approach to show product evolution.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
25
Includes a blackbox warning text block as a competitive/safety barrier context.Equillium | Investor Presentation Deck | 32 slides · Equillium
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
10
The slide outlines the methodology and validation of a clinical trial.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
11
The slide uses a table to compare clinical outcomes across patient subgroups (all, resistant, refractory) and a callout box for key takeaways.Genelux | Investor Presentation Deck | 37 slides · Genelux
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
05
The slide uses a combination of summary text, callouts for specific financial impacts, and detailed tables for per-day sales and organic growth metrics.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
The slide uses a combination of bar charts for absolute dollar values and line charts for percentage margins.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
Includes footnotes detailing reconciliation and definitions.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
08
The slide uses a table to compare performance metrics across different product lines.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
09
Includes footnotes regarding reconciliation and tax rate definitions.GMS | Results Presentation Deck | 19 slides · GMS
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
20
The slide uses a causal chain to link cellular pathology to systemic organ damage.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
21
The slide uses a bar chart to compare hematologic and cardiac response rates across different therapies.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
22
The slide uses a table structure to contrast patient segments and includes a bar chart visualization for patient growth.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
23
The slide explicitly notes that these are cross-trial comparisons and not head-to-head results.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
24
Includes a footnote citing FDA approval precedents for similar single-arm studies.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
25
Uses a visual icon-grid to represent market expansion.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
26
Includes detailed clinical trial citations in the footer.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
27
The slide uses a two-column layout to separate milestones by drug candidate.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
28
The slide uses a standard pharmaceutical pipeline table format.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
29
Includes a comparative table of clinical outcomes (ORR/CR) for NXC-201 vs. Allogeneic CAR-T and Bispecifics.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
30
The slide uses a stylized area chart to represent market segments and their respective valuations.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
39
Uses a stacked bar chart to visualize the 'dollar gap' between ad spend allocation and consumer time spent.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
40
Uses screenshots of news articles as evidence of market trends.Innovid | Investor Day Presentation Deck | 74 slides · Innovid
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
38
The slide uses a numbered process flow to detail specific GHG reduction commitments.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Cost Of Inaction1 hit
39
Includes a visual representation of the 6x land footprint restoration goal.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Cost Of Inaction1 hit
40
The diagram is a circular process map showing the lifecycle of luxury goods.Kering | ESG Presentation Deck | 80 slides · Moelis & Company
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Cost Of Inaction1 hit
07
This is a stylistic section divider slide with an abstract background.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
08
The slide uses a biological pathway diagram to illustrate the mechanism of action for a drug candidate.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
09
Includes a mechanism of action diagram, a market data table, and a callout box on competitive limitations.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit